NCT03370328

Brief Summary

The purpose of this study is to determine if aromatherapy (essential oil) is effective at reducing up-set stomach and vomiting after surgery and in reducing the need for up-set stomach medications

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
143

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 12, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

March 12, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2018

Completed
Last Updated

September 4, 2018

Status Verified

August 1, 2018

Enrollment Period

4 months

First QC Date

December 7, 2017

Last Update Submit

August 31, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean change in nausea score

    Nausea will be score on a scale of 0-3 with zero indicated no nausea.

    baseline to 24 hours

Study Arms (3)

Peppermint oil

EXPERIMENTAL

post-op surgical patients

Other: Peppermint oil

Ginger oil

EXPERIMENTAL

post-op surgical patients

Other: Ginger oil

Peppermint and ginger oil

EXPERIMENTAL

post-op surgical patients

Other: Peppermint oilOther: Ginger oil

Interventions

The study product is a commercial essential oil product and nasal inhaler. It is to be prepared by a trained, independent individual who will add 4 drops of one of the three oils/oil combinations. The subject will be instructed to twist off the cap and position inhaler in such a way as to allow the subject to inhale the vapors; it can be reused for multiple administrations. Essential oils have been the subject of other studies in treating nausea. If nausea is unrelieved, treatment will progress to the ordered antiemetic.

Peppermint and ginger oilPeppermint oil

The study product is a commercial essential oil product and nasal inhaler. It is to be prepared by a trained, independent individual who will add 4 drops of one of the three oils/oil combinations. The subject will be instructed to twist off the cap and position inhaler in such a way as to allow the subject to inhale the vapors; it can be reused for multiple administrations. Essential oils have been the subject of other studies in treating nausea. If nausea is unrelieved, treatment will progress to the ordered antiemetic.

Ginger oilPeppermint and ginger oil

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • post-op surgical patients at least 18 years of age or older
  • the ability to understand and follow directions for use of essential oils
  • the ability to understand and give informed consent to study
  • the ability to understand, read and write English
  • ambulatory or short-stay/23-hour patients

You may not qualify if:

  • History of any pulmonary disease, including but not limited to: asthma, COPD, OSA, chronic bronchitis, pulmonary and ear, nose, throat (ENT) surgery patients
  • Allergy to any of the ingredients in the essential oils
  • Sensitivity to strong odors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rochester Medical Center

Rochester, New York, 14642, United States

Location

MeSH Terms

Conditions

Nausea

Interventions

peppermint oilginger extract

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Maxine Fearrington, MS

    University of Rochester, Strong Memorial Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Nurse

Study Record Dates

First Submitted

December 7, 2017

First Posted

December 12, 2017

Study Start

March 12, 2018

Primary Completion

June 30, 2018

Study Completion

June 30, 2018

Last Updated

September 4, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations